The SonoTran® System is a novel proprietary ultrasound device uniquely designed by OxSonics to image, treat, and monitor target tissue regions in the oncology ward setting. The System uses relatively low diagnostic-level ultrasound pressures focused to a user-selectable target region.
For use at the chair-side or bedside in oncology ward / infusion center settings.
Enhanced Treatment Guidance
Potential for co-registration with previously acquired high-resolution patient specific diagnostic CT or MR to real-time ultrasound.
Real Time Treatment Mapping for Optimal Anatomical Coverage
Real-time on-screen mapping and monitoring of treatment using OxSonics’ proprietary patent protected “see-as-you-treat” technology.
Working in collaboration with world-leading oncology radiologists, the enhanced treatment guidance and optimal anatomical guidance features are designed to make the SonoTran® System intuitive and easy to use by trained junior radiologists or sonographers.
OxSonics plans to provide an installed base of SonoTran® Systems alongside the provision of training and service and maintenance of Systems. This allows our strategic partners to focus on the commercialisation of the SonoTran® Particles in combination with their therapeutic agent.
For investigational use only, not approved for sale.